Cingulate and ADHD Expert Dr. Ann Childress, MD to : compare

KANSAS CITY, Kan., June 02, 2022 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary...

Related Keywords

Nevada , United States , Kansas , Kansas City , American , Matt Kreps , Thomas Dalton , Las Vegas , Melyssa Weible , Shanej Schaffer , Benzinga Youtube , Ann Childress , Annc Childress , American Psychiatric Association , American Academy Of Child , Darrow Associates , Cingulate Inc , Clinical Research Of Southern Nevada , Nasdaq , Novartis , Pfizer , Astrazeneca , Nevada Psychiatric Association , Elixir Health Public Relations , American Professional Society , Precision Timed Release , Benzinga All Access , Hyperactivity Disorder , Related Disorders , Education Director , American Academy , Clinical Research , Southern Nevada , Behavioral Medicine , Dose Study , Public Relations , Nasdaq Cingw , King , Cingulate , Drug Delivery Platform , Drug Delivery Technology , Ktr , Adhd , Anxiety , Benzinga ,